E Fund Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$344K	Buy	+111,950	New	+$433K	0.01%	359
2025 Q2	$201K	Sell	39,653 -16,272	-29%	-$79.9K	0.01%	362
2025 Q1	$296K	Buy	55,925 +13,604	+32%	+$99.2K	0.01%	317
2024 Q4	$286K	Sell	42,321 -1,097	-3%	-$7.38K	0.01%	324
2024 Q3	$286K	Buy	43,418 +19,253	+80%	+$138K	0.01%	266
2024 Q2	$181K	Sell	24,165 -14,562	-38%	-$127K	0.01%	296
2024 Q1	$386K	Sell	38,727 -15,367	-28%	-$171K	0.02%	229
2023 Q4	$533K	Sell	54,094 -2,638	-5%	-$18.8K	0.03%	149
2023 Q3	$434K	Buy	56,732 +39,503	+229%	+$394K	0.03%	148
2023 Q2	$129K	Sell	17,229 -4,188	-20%	-$29.3K	0.01%	293
2023 Q1	$143K	Sell	21,417 -5,694	-21%	-$45.2K	0.01%	313
2022 Q4	$209K	Buy	27,111 +15,252	+129%	+$150K	0.02%	297
2022 Q3	$126K	Buy	+11,859	New	+$120K	0.01%	323